| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7670195
[patent_doc_number] => 20110319464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA'
[patent_app_type] => utility
[patent_app_number] => 13/228649
[patent_app_country] => US
[patent_app_date] => 2011-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7507
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13228649
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/228649 | METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA | Sep 8, 2011 | Abandoned |
Array
(
[id] => 8381429
[patent_doc_number] => 20120225057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/228288
[patent_app_country] => US
[patent_app_date] => 2011-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64410
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13228288
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/228288 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES | Sep 7, 2011 | Abandoned |
Array
(
[id] => 7808024
[patent_doc_number] => 20120058978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'METHOD FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CANCERS AND COMPOSITIONS RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 13/222021
[patent_app_country] => US
[patent_app_date] => 2011-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 10433
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058978.pdf
[firstpage_image] =>[orig_patent_app_number] => 13222021
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/222021 | Method for the treatment of central nervous system cancers and compositions related thereto | Aug 30, 2011 | Issued |
Array
(
[id] => 7720913
[patent_doc_number] => 20120010248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/214937
[patent_app_country] => US
[patent_app_date] => 2011-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 30902
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010248.pdf
[firstpage_image] =>[orig_patent_app_number] => 13214937
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/214937 | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof | Aug 21, 2011 | Issued |
Array
(
[id] => 9042411
[patent_doc_number] => 20130245050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'Use of N-Phenylethylpyraozole Carboxamide Derivatives or Salts Thereof for Extending Shelf Life of Fruits and Vegetables'
[patent_app_type] => utility
[patent_app_number] => 13/817052
[patent_app_country] => US
[patent_app_date] => 2011-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4381
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817052
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/817052 | Use of N-Phenylethylpyraozole Carboxamide Derivatives or Salts Thereof for Extending Shelf Life of Fruits and Vegetables | Aug 14, 2011 | Abandoned |
Array
(
[id] => 8126801
[patent_doc_number] => 20120087947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR TREATING DERMATITIS'
[patent_app_type] => utility
[patent_app_number] => 13/209803
[patent_app_country] => US
[patent_app_date] => 2011-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12709
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20120087947.pdf
[firstpage_image] =>[orig_patent_app_number] => 13209803
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/209803 | Use of 2,5-dihydroxybenzene derivatives for treating dermatitis | Aug 14, 2011 | Issued |
Array
(
[id] => 9311841
[patent_doc_number] => 08653058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => 'Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits'
[patent_app_type] => utility
[patent_app_number] => 13/207337
[patent_app_country] => US
[patent_app_date] => 2011-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7577
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13207337
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/207337 | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits | Aug 9, 2011 | Issued |
Array
(
[id] => 7587392
[patent_doc_number] => 20110281902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'COMBINATIONS COMPRISING A PROTEIN KINASE INHIBITOR BEING A PYRIMIDYLAMINOBENZAMIDE COMPOUND AND A HSP90 INHIBITOR SUCH AS 17-AAG'
[patent_app_type] => utility
[patent_app_number] => 13/195369
[patent_app_country] => US
[patent_app_date] => 2011-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6632
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281902.pdf
[firstpage_image] =>[orig_patent_app_number] => 13195369
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/195369 | COMBINATIONS COMPRISING A PROTEIN KINASE INHIBITOR BEING A PYRIMIDYLAMINOBENZAMIDE COMPOUND AND A HSP90 INHIBITOR SUCH AS 17-AAG | Jul 31, 2011 | Abandoned |
Array
(
[id] => 7657406
[patent_doc_number] => 20110306675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING NF-KB MEDIATED TUMORIGENICITY AND ADHESION-DEPENDENT SURVIVAL OF CANCER CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/195810
[patent_app_country] => US
[patent_app_date] => 2011-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32415
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306675.pdf
[firstpage_image] =>[orig_patent_app_number] => 13195810
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/195810 | COMPOSITIONS AND METHODS FOR INHIBITING NF-KB MEDIATED TUMORIGENICITY AND ADHESION-DEPENDENT SURVIVAL OF CANCER CELLS | Jul 31, 2011 | Abandoned |
| 13/194379 | COMPOUND FOR ENHANCING OSTEOBLAST DIFFERENTIATION AND INHIBITING OSTEOCLAST DIFFERENTIATION AND PHARMACEUTICAL COMPOSITION THEREOF | Jul 28, 2011 | Abandoned |
Array
(
[id] => 8940573
[patent_doc_number] => 20130190370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor'
[patent_app_type] => utility
[patent_app_number] => 13/812793
[patent_app_country] => US
[patent_app_date] => 2011-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 26714
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812793
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/812793 | Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor | Jul 26, 2011 | Abandoned |
Array
(
[id] => 9094970
[patent_doc_number] => 20130274281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'METHODS OF TREATING METASTATIC BREAST CANCER WITH 4-IODO-3-NITROBENZAMIDE AND IRINOTECAN'
[patent_app_type] => utility
[patent_app_number] => 13/811193
[patent_app_country] => US
[patent_app_date] => 2011-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 39459
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811193
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/811193 | METHODS OF TREATING METASTATIC BREAST CANCER WITH 4-IODO-3-NITROBENZAMIDE AND IRINOTECAN | Jul 18, 2011 | Abandoned |
Array
(
[id] => 10069587
[patent_doc_number] => 09107922
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Pyrimidinecarboxamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/808508
[patent_app_country] => US
[patent_app_date] => 2011-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9666
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808508
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/808508 | Pyrimidinecarboxamide derivatives | Jul 12, 2011 | Issued |
Array
(
[id] => 7720895
[patent_doc_number] => 20120010230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING'
[patent_app_type] => utility
[patent_app_number] => 13/179438
[patent_app_country] => US
[patent_app_date] => 2011-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 59101
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010230.pdf
[firstpage_image] =>[orig_patent_app_number] => 13179438
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/179438 | METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING | Jul 7, 2011 | Abandoned |
Array
(
[id] => 9004405
[patent_doc_number] => 20130225530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'WOGONIN FOR THE PREVENTION AND THERAPY OF CARDIAC HYPERTROPHY'
[patent_app_type] => utility
[patent_app_number] => 13/809312
[patent_app_country] => US
[patent_app_date] => 2011-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7724
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809312
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/809312 | WOGONIN FOR THE PREVENTION AND THERAPY OF CARDIAC HYPERTROPHY | Jul 5, 2011 | Abandoned |
Array
(
[id] => 8792730
[patent_doc_number] => 20130109699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'TETRAHYDROCARBOLINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/807947
[patent_app_country] => US
[patent_app_date] => 2011-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 95025
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807947
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/807947 | Tetrahydrocarboline derivative | Jul 4, 2011 | Issued |
Array
(
[id] => 11767848
[patent_doc_number] => 09376424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'Methods for treating post traumatic stress disorder'
[patent_app_type] => utility
[patent_app_number] => 13/807613
[patent_app_country] => US
[patent_app_date] => 2011-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 37791
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807613
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/807613 | Methods for treating post traumatic stress disorder | Jun 30, 2011 | Issued |
| 13/174780 | NOVEL SOLID FORMS OF TACEDINALINE | Jun 30, 2011 | Abandoned |
Array
(
[id] => 8228573
[patent_doc_number] => 20120142780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'USE OF 2,5-DIHYDROXYBENZENESULFONIC ACID IN THE MANUFACTURING OF MEDICINES, APPLICABLE TO THE TREATMENT OF ANGIODEPENDENT DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/169781
[patent_app_country] => US
[patent_app_date] => 2011-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5827
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169781
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/169781 | Use of 2,5-dihydroxybenzenesulfonic acid in the manufacturing of medicines, applicable to the treatment of angiodependent diseases | Jun 26, 2011 | Issued |
Array
(
[id] => 8792756
[patent_doc_number] => 20130109726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'SUSTAINED-RELEASE THERAPEUTIC AGENT FOR HYPERTENSION AND RENAL DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/806370
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3198
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806370
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/806370 | SUSTAINED-RELEASE THERAPEUTIC AGENT FOR HYPERTENSION AND RENAL DYSFUNCTION | Jun 23, 2011 | Abandoned |